The skeletal metastatic complications of renal cell carcinoma

  • Authors:
    • J. Zekri
    • N. Ahmed
    • R. E. Coleman
    • B. W. Hancock
  • View Affiliations

  • Published online on: August 1, 2001     https://doi.org/10.3892/ijo.19.2.379
  • Pages:379-382
0

Abstract

Of the 103 patients with advanced renal cell carcinoma 31 (30%) developed symptomatic radiologically confirmed skeletal metastases. These were typically lytic, predominantly affecting the axial skeleton and associated with considerable skeletal morbidity. Solitary bone lesions occurred in 14 (45%) of patients. The median survival of patients with bone metastases was 12 months. Hypercalcaemia was common in patients both with (29%) and without (44%) bone metastases. The number and rate of skeletal related events was similar to that seen from bone metastases from breast cancer. It would therefore be appropriate to evaluate the effectiveness of bisphosphonate treatment for reducing skeletal morbidity in advanced renal cell cancer with bone metastases.

Related Articles

Journal Cover

August 2001
Volume 19 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

2016 Impact Factor: 3.079
Ranked #33/217 Oncology
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Zekri, J., Ahmed, N., Coleman, R.E., & Hancock, B.W. (2001). The skeletal metastatic complications of renal cell carcinoma. International Journal of Oncology, 19, 379-382. https://doi.org/10.3892/ijo.19.2.379
MLA
Zekri, J., Ahmed, N., Coleman, R. E., Hancock, B. W."The skeletal metastatic complications of renal cell carcinoma". International Journal of Oncology 19.2 (2001): 379-382.
Chicago
Zekri, J., Ahmed, N., Coleman, R. E., Hancock, B. W."The skeletal metastatic complications of renal cell carcinoma". International Journal of Oncology 19, no. 2 (2001): 379-382. https://doi.org/10.3892/ijo.19.2.379